TY - JOUR T1 - Asthma research in Europe: a transformative agenda for innovation and competitiveness JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02294-2016 VL - 49 IS - 5 SP - 1602294 AU - Nikolaos G. Papadopoulos AU - Aggeliki Androutsopoulou AU - Cezmi Akdis AU - Sven-Erik Dahlén AU - Ratko Djukanovic AU - Jessica Edwards AU - Luis Garcia-Marcos AU - Sebastian L. Johnston AU - Maciek Kupczyk AU - Thomas R. Martin AU - David Myles AU - Susanna Palkonen AU - Pippa Powell AU - John Riley AU - Samantha Walker Y1 - 2017/05/01 UR - http://erj.ersjournals.com/content/49/5/1602294.abstract N2 - Asthma is highly prevalent, often starting in infancy and persisting throughout life, and is associated with high morbidity and burden. It is a major global health challenge with growing impact, affecting more than 300 million people worldwide and at least 10% of all Europeans [1]. Furthermore, it is the most prevalent long-term condition in children [2]. Approximately 5–10% of asthma cases are so severe that current treatments do not work, and over five million people in the European Union (EU) fall into this category.Asthma research in Europe: a transformative agenda for innovation and competitiveness http://ow.ly/YssR30aNG9h ER -